Abstract
An 18-month-old girl with supraventricular tachycardia was given a dose of intravenous verapamil and suffered a short myoclonic seizure which occurred again when she was given second and third doses. In the absence of any predisposing factors, direct drug reaction was implicated as the cause of the seizure.
MeSH terms
-
Anti-Arrhythmia Agents / adverse effects*
-
Anti-Arrhythmia Agents / therapeutic use
-
Female
-
Humans
-
Infant
-
Injections, Intravenous
-
Myoclonus / chemically induced*
-
Tachycardia, Supraventricular / drug therapy
-
Verapamil / adverse effects*
-
Verapamil / therapeutic use
Substances
-
Anti-Arrhythmia Agents
-
Verapamil